MTND2P19

Across TCGA pan-cancer cohorts, MTND2P19 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTND2P19’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where MTND2P19 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND2P19 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

ESCA are the cancer types where MTND2P19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND2P19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	All	−0.086	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

MTND2P19–ESCA

Open the ESCA breakdown →